Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 9:8:716198.
doi: 10.3389/fcvm.2021.716198. eCollection 2021.

Case Report: Lymphohistiocytic Myocarditis With Severe Cardiogenic Shock Requiring Mechanical Cardiocirculatory Support in Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection

Affiliations
Case Reports

Case Report: Lymphohistiocytic Myocarditis With Severe Cardiogenic Shock Requiring Mechanical Cardiocirculatory Support in Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection

Xavier Bemtgen et al. Front Cardiovasc Med. .

Abstract

Multisystem Inflammatory Syndrome (MIS) is a novel hyperinflammatory syndrome associated with SARS-CoV-2 infection. It predominantly affects children (MIS-C) a few weeks after a usually asymptomatic SARS-CoV-2 infection and is only rarely seen in adults above 21 years (MIS-A). Only scarce data on histological findings in both pediatric and adult patients has been published so far. An 18-year-old male patient was admitted to hospital in a febrile state, which progressed to severe cardiogenic shock and multi-organ failure requiring extracorporeal life support. Myocardial biopsy revealed small vessel-associated immune cell infiltrates. Diagnosis of MIS-C was made after ruling out all potential differential diagnosis. Use of immunosuppressive treatment with steroids, interleukin-1 blockade and high-dose intravenous immunoglobulins resulted in the patient's full recovery. Multisystem Inflammatory Syndrome (MIS) is a new differential diagnosis of cardiac dysfunction in pediatric and adult patients. The lack of myocardial necrosis differentiates the disease from other viral myocarditis and offers an explanation for the fast response to immunomodulatory therapy and the favorable prognosis. The preceding SARS-CoV-2 infection might only have been mildly symptomatic or even asymptomatic.

Keywords: COVID-19; Impella®; MIS-C; Multisystem Inflammatory Syndrome in children; V-A ECMO; myocardial biopsy.

PubMed Disclaimer

Conflict of interest statement

AS reports research grants and lecture fees from CytoSorbents and lecture fees from Abiomed, both outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Clinical and treatment parameters of the patient during the 1st month after hospital admission. (A–H) show the time course of different laboratory parameters during the first 30 days following hospital admission. (I) displays a timeline of the different clinical parameters and specific therapy during the first 30 days.
Figure 2
Figure 2
Histopathology and immunohistochemistry of the patient's endomyocardial biopsy. Serial tissue sections of paraffin-embedded endomyocardial biopsies reveal perivascular fibrosis in absence of myocyte necrosis [Masson Trichrome (A) and HE (B) stainings, see circle] and severe infiltration of CD68+ macrophages (C) and CD3+ T cells (D) primarily around intracardiac small vessels (see circle, magnification x200). HE, hematoxylin-eosin; CD, cluster of differentiation.

References

    1. Izda V, Jeffries MA, Sawalha AH. COVID-19: a review of therapeutic strategies and vaccine candidates. Clin Immunol. (2021) 222:108634. 10.1016/j.clim.2020.108634 - DOI - PMC - PubMed
    1. Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat F, Krammer F, et al. . Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell. (2020) 183:982–95.e14. 10.1016/j.cell.2020.09.034 - DOI - PMC - PubMed
    1. Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. . American College of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS–CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol. (2021) 73:41616. 10.1002/art.41616 - DOI - PMC - PubMed
    1. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. (2020) 395:1607–8. 10.1016/S0140-6736(20)31094-1 - DOI - PMC - PubMed
    1. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. . Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. (2020) 369:m2094. 10.1136/bmj.m2094 - DOI - PMC - PubMed

Publication types